These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population. Goharian TS; Goetze JP; Faber J; Andersen LB; Grøntved A; Jeppesen JL Am J Hypertens; 2017 Jun; 30(6):561-568. PubMed ID: 28338810 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke. Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a one-year multi-component day-camp intervention for overweight children: study protocol of the Odense overweight intervention study (OOIS). Larsen KT; Huang T; Møller NC; Andersen LB; Ried-Larsen M BMC Public Health; 2014 Apr; 14():313. PubMed ID: 24708676 [TBL] [Abstract][Full Text] [Related]
8. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800 [TBL] [Abstract][Full Text] [Related]
9. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293 [TBL] [Abstract][Full Text] [Related]
10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
19. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312 [TBL] [Abstract][Full Text] [Related]
20. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]